Table 5.
Mean values across for primary and secondary outcomes.
| Baseline M (SD) | Discharge M (SD) | 3-mon FU M (SD) | 6-mon FU M (SD) | Greenhouse-Geisser F | Partial Eta2 | |
|---|---|---|---|---|---|---|
| Primary | ||||||
| FOPQ-Fear (n=25) | 28.6 (11.9) | 21.6 (14.4) | 18.0 (14.1)d | 17.6 (13.1)e | 9.56 | .285* |
| FOPQ-Avoidance (n=25) | 24.2 (9.2) | 14.9 (11.7)a | 12.6 (9.9)d | 12.4 (9.7)e | 20.94 | .466* |
| PHODA-PH (n=24) | 5.01 (2.34) | 2.83 (2.45)a | 1.89 (2.31)b,d | 1.94 (1.92)c,e | 22.20 | .491* |
| PHODA-AP (n=24) | 5.09 (1.92) | 2.82 (2.40)a | 1.91 (2.24)b,d | 2.04 (2.13)e | 26.21 | .533* |
| Secondary | ||||||
| Functional Disability (n=24) | 25.0 (10.8) | 15.3 (11.9)a | 10.4 (11.2)b,d | 11.0 (10.8)e | 26.38 | .534* |
| School Functioning (n=24) | 45.5 (20.9) | 58.1 (17.8)a | 67.1 (15.1)b,d | 68.9 (20.9)c,e | 19.30 | .456* |
| Pain (n=25) | 6.00 (2.52) | 4.36 (2.90)a | 3.68 (3.09)d | 3.8 (3.1)e | 7.37 | .235* |
| Pain Catastrophizing (n=24) | 28.7 (12.7) | 21.6 (14.4)a | 16.0 (12.3)b,d | 17.8 (13.7)e | 15.22 | .398* |
| Acceptance-AE (n=24) | 19.6 (7.19) | 26.2 (8.31)a | 30.6 (9.05)d | 30.3 (10.4)e | 14.40 | .385* |
| Acceptance-PW (n=25) | 13.1 (5.39) | 16.8 (7.02) | 21.5 (6.10)b,d | 21.6 (8.50)e | 14.10 | .370* |
Note.
*
p ≤ .001.
Using Bonferroni post-hoc pair-wise comparions:
a
significant change from pre to post
b
significant change from post to 3 month follow-up
c
significant change from post to 6 month follow up
d
significant change from pre to 3 month follow-up
e
significant change from pre to 6 month follow up. Partial eta2 where 0.1 is a small effect, 0.25 is a medium effect and 0.4 is a large effect. Variability of n is due to incomplete patient self-report data.
FOPQ=Fear of Pain Questionnaire; PHODA=Photographs of Daily Activities; PH=perceived harm; AP=anticipated pain; AE=Activity Engagement; PW=Pain Willingness